Accepted answer
1 mg a week is 52 mg a year and 4.3 mg in an average month — put every route on that denominator before comparing anything. Cost per milligram is the only figure that survives the comparison, because the presentations differ: a licensed pen prices a dose, a compounding pharmacy prices a vial, and a research supplier prices a mass. Divide each one's twelve-month cost by 52 mg and the three become the same number in the same unit. Then add what the cheapest route does not include — independent purity and content testing, the vials you discard, and the postage — because a route that needs testing to be trustworthy has that testing in its cost per milligram whether you account for it or not.
Start by listing every cost in the chain, since carriage, testing and wastage frequently exceed the difference in headline price.
Wastage from a reconstituted vial discarded at the end of its in-use period is a genuine cost, and it is a function of the diluent volume chosen at reconstitution rather than of anything the supplier did.
Change one number and it reverses: if B assays at 82 per cent, that is 8.2 mg for £52, or £6.34/mg, and the cheaper vial is now the more expensive peptide.
Syringe dead-space volumes are published per design, with fixed-needle insulin syringes under 5 microlitres and conventional luer designs at 35 microlitres or more.
Include carriage and testing as per-milligram terms. They dominate small orders.
2Worth adding that legal position and enforcement posture are different things. – mz_4113 7 months ago 3I have kept every invoice and declaration, which I gather is the useful habit. – tri_gly_ala 9 months ago add a comment